Omeros | OMER - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Adma Biologics USD 20.52M 2M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cytokinetics USD 24.71M 80.91M 2026-03
Gilead Sciences USD 645M 70M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Immunic USD 11.01M 873K 2026-03
Insmed USD 73.38M 6.53M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
MacroGenics USD 4.29M 500K 2026-03
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 14.01M 1.14M 2026-03
Pfizer USD 4.51B 734M 2026-03
Rockwell Medical USD 1.5M 423K 2025-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
United Therapeutics USD 498.3M 491.2M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Xoma USD 2.65M 1.52M 2025-09